Physicians Seek Unrestricted Coverage Of NaF-18 PET For Bone Metastasis
This article was originally published in The Gray Sheet
Executive Summary
Recent shortages of an isotope commonly used in bone scans have prompted several professional societies to urge CMS to offer cancer patients broad access to sodium fluoride-18 positron emission tomography to identify bone metastasis